Skip to main content

France

25
Aug 2021

New experiments under Article 51 of the Social Security Financing Act in France

The French Ministry of Solidarity and Health constantly announces the new experiments initiated under Article 51 of the Social Security Financing Act. These experiments are focused on various topics concerning medical technologies and the organization of care. At the end of July, three new experiments related to the system of care for people with disabilities, families with overweight children, and homeless drug users were announced.
20
Aug 2021

Final 2021 DRG manual published in France

On July 30, 2021, the final version of the French DRG manual was published on the website of the Technical Agency for Information on Hospitalizations (ATIH). No new DRGs or other changes compared to the preliminary version published in March 2021 have been introduced.
16
Aug 2021

Applications for coverage with evidence development programs released in France

On July 29, 2021, the French Ministry of Solidarity and Health published the instruction related to the 2021 application for coverage with evidence development programs. In the instruction, the specific fields of research, the application procedures, and the deadlines for applications for different types of projects (PHRC, PRME, PREPS, PRT) are specified.
19
Jul 2021

2021 PHRC and PRME projects awarded announced in France

On June 24, 2021, the list of awarded PHRC and PRME projects, submitted in 2020, was published. A total of 137 PHRC and nine PRME projects were awarded, and they concern various technology groups, such as gynecology, nephrology, neurology, cardiovascular, etc.
15
Jul 2021

Recommendations about add-on reimbursement for medical devices in France in June 2021

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in June 2021. Recommendations concern cardiovascular and peripheral vascular devices, orthopedic devices, liquid for embolization, and medical aids.
23
Jun 2021

Transitional coverage as early access to reimbursement of innovative medical devices in France

Transitional coverage of certain products and services (prise en charge (PEC) transitoire), according to article L165-1-5 of the Social Security, is a newly-established pathway to obtain reimbursement for CE-marked medical devices intended for the treatment of rare or serious diseases, or compensation for a disability. The coverage is provided for 12 months with an opportunity for renewal before submitting an application for inclusion in the List of Reimbursable Products and Services (LPPR).
14
Jun 2021

Recommendations about add-on reimbursement for medical devices in France in May 2021

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2021. Recommendations concern orthopedic devices, cardiovascular, peripheral vascular, and neurovascular devices, medical aids, and pulmonary artery pressure sensor.
07
Apr 2021

Order on the 2021 DRG system published in France

On March 31, 2021, the Order of the Ministry of Solidarity and Health on the 2021 DRG system was published in the Official Journal of the French Republic. The Order includes information on the 2021 updates of the DRG system, DRG tariffs, supplements for private and public hospitals, as well as the tariffs for specific packages (emergency treatment package, ATU; small equipment package, FFM; safety and hospital environment package, SE; administration package for pharmaceutical products, services, and specialties in a hospital environment, APE) applicable to the procedures performed in a hospital environment but without hospitalization, etc.
17
Mar 2021

The updated LPPR list for add-on reimbursement published in France

On February 18, 2021, the updated List of Reimbursable Products and Services (LPPR) was published. It contains new devices included in the LPPR list in January-February 2021, as well as other modifications made during this period. The newly-included devices belong to the cardiovascular (TAVI), ENT (cochlear and brainstem implants), and diagnostic imaging (FFR) technology groups.